Hikari Power LTD Acadia Pharmaceuticals Inc Transaction History

Hikari Power LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 31, 2019	SELL	$22.22 - $44.01 $411,847 - $815,725	-18,535 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$23.32 - $28.12 $34,163 - $41,195	-1,465 Reduced 7.32%	18,535 $495,000
Q4 2018 Jan 29, 2019	BUY	$14.32 - $22.92 $286,400 - $458,400	20,000 New	20,000 $323,000
Q3 2018 Oct 31, 2018	SELL	$13.03 - $21.81 $781,800 - $1.31 Million	-60,000 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$15.07 - $22.34 $301,400 - $446,800	20,000 Added 50.0%	60,000 $916,000
Q3 2017 Nov 08, 2017	SELL	$29.49 - $38.37 $589,800 - $767,400	-20,000 Reduced 33.33%	40,000 $1.51 Million
Q2 2017 Aug 09, 2017	BUY	N/A	60,000	60,000 $1.67 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.68B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Hikari Power LTD, based on Form 13F filings with the SEC.

Stay updated on Hikari Power LTD with notifications on news.